Liu X - Search Results

1

Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression.

Niu M, Cai W, Liu H, Chong Y, Hu W, Gao S, Shi Q, Zhou X, Liu X, Yu R. Niu M, et al. Among authors: liu h, liu x. J Pharmacol Sci. 2015 Jul;128(3):131-6. doi: 10.1016/j.jphs.2015.06.005. Epub 2015 Jun 25. J Pharmacol Sci. 2015. PMID: 26154848 Free article.

2

Tautomycetin induces apoptosis by inactivating Akt through a PP1-independent signaling pathway in human breast cancer cells.

Niu M, Sun Y, Liu X, Tang L, Qiu R. Niu M, et al. Among authors: liu x. J Pharmacol Sci. 2013;121(1):17-24. doi: 10.1254/jphs.12206fp. Epub 2012 Dec 26. J Pharmacol Sci. 2013. PMID: 23269238 Free article.

3

CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin.

Liu X, Niu M, Xu X, Cai W, Zeng L, Zhou X, Yu R, Xu K. Liu X, et al. J Pharmacol Sci. 2014;124(4):486-93. doi: 10.1254/jphs.13240fp. J Pharmacol Sci. 2014. PMID: 24739265 Free article.

4

Mst1 regulates glioma cell proliferation via the AKT/mTOR signaling pathway.

Chao Y, Wang Y, Liu X, Ma P, Shi Y, Gao J, Shi Q, Hu J, Yu R, Zhou X. Chao Y, et al. Among authors: liu x. J Neurooncol. 2015 Jan;121(2):279-88. doi: 10.1007/s11060-014-1654-4. Epub 2014 Nov 6. J Neurooncol. 2015. PMID: 25373346

5

Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1.

Liu X, Cai W, Niu M, Chong Y, Liu H, Hu W, Wang D, Gao S, Shi Q, Hu J, Zhou X, Yu R. Liu X, et al. Among authors: liu h. J Neurooncol. 2015 Feb;121(3):469-77. doi: 10.1007/s11060-014-1664-2. Epub 2014 Dec 21. J Neurooncol. 2015. PMID: 25528634

6

Piperlongumine selectively suppresses ABC-DLBCL through inhibition of NF-κB p65 subunit nuclear import.

Niu M, Shen Y, Xu X, Yao Y, Fu C, Yan Z, Wu Q, Cao J, Sang W, Zeng L, Li Z, Liu X, Xu K. Niu M, et al. Among authors: liu x. Biochem Biophys Res Commun. 2015 Jul 10;462(4):326-31. doi: 10.1016/j.bbrc.2015.04.136. Epub 2015 May 13. Biochem Biophys Res Commun. 2015. PMID: 25979358

7

Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.

Niu M, Chong Y, Han Y, Liu X. Niu M, et al. Among authors: liu x. Cancer Biol Ther. 2015;16(7):1110-8. doi: 10.1080/15384047.2015.1047569. Epub 2015 May 21. Cancer Biol Ther. 2015. PMID: 25996664 Free PMC article.

8

Piperlongumine is a novel nuclear export inhibitor with potent anticancer activity.

Niu M, Xu X, Shen Y, Yao Y, Qiao J, Zhu F, Zeng L, Liu X, Xu K. Niu M, et al. Among authors: liu x. Chem Biol Interact. 2015 Jul 25;237:66-72. doi: 10.1016/j.cbi.2015.05.016. Epub 2015 May 28. Chem Biol Interact. 2015. PMID: 26026911

9

Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.

Liu X, Chong Y, Liu H, Han Y, Niu M. Liu X, et al. Among authors: liu h. J Ovarian Res. 2015 Jun 10;8:35. doi: 10.1186/s13048-015-0166-y. J Ovarian Res. 2015. PMID: 26055813 Free PMC article.

10

Hugl-1 inhibits glioma cell growth in intracranial model.

Liu X, Lu D, Ma P, Liu H, Cao Y, Sang B, Zhu X, Shi Q, Hu J, Yu R, Zhou X. Liu X, et al. Among authors: liu h. J Neurooncol. 2015 Oct;125(1):113-21. doi: 10.1007/s11060-015-1901-3. Epub 2015 Sep 4. J Neurooncol. 2015. PMID: 26341367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135,391 results

Search Page

Filters